EUVIMEDEUVIMED entdecken
Crossref

Combination therapy strategies against multidrug resistant bacteria in vitro and in vivo

Daliang Wang, Jie Yang, Lilan Yang, Yanglin Du, Qunchao Zhu, Chendong Ma, Dongdong Zhou

Letters in Applied Microbiology · 2024

DOI: 10.1093/lambio/ovae129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Letters in Applied Microbiology, 2024. Verfasst von Daliang Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, The First People's Hospital Of Jiashan County, Jiaxing 314100 Zhejiang, China. Hauptthemen laut MEDLINE: Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents, Polymyxin B, Gram-Negative Bacteria. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Exploring effective combination antibacterial therapies has become a research focus. This study selected seven common antibiotics to perform a series of tests on different Gram-negative bacteria isolated from clinical samples of chronic obstructive pulmonary disease patients. More than 70% of the strains exhibited multidrug resistance but remained sensitive to polymyxin B. The checkerboard assay revealed a significant synergistic effect between polymyxin B and tetracycline against different resistant strains, with fractional inhibitory concentration index values consistently below 0.5. Further time-kill curve analysis demonstrated that the use of minimal inhibit concentration of polymyxin B or tetracycline alone had limited bactericidal effects, while their combination significantly reduced bacterial counts by 2–3 log colony-forming units within 12 h. Additionally, the survival rate of larvae treated with the polymyxin B and tetracycline combination was significantly higher than that of the mono-therapy and untreated groups. In brief, this study demonstrates that the combination of polymyxin B and tetracycline exhibits potent antibacterial activity against multidrug resistant Gram-negative bacteria both in vitro and in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, Multiple, BacterialAnti-Bacterial AgentsPolymyxin BGram-Negative BacteriaMicrobial Sensitivity TestsTetracyclineDrug Therapy, CombinationDrug SynergismAnimalsHumansGram-Negative Bacterial InfectionsPulmonary Disease, Chronic Obstructive

Stichwörter der Autor:innen

COPDantibacterialcombinationpolymyxin Btetracycline

Substanzen

Anti-Bacterial AgentsPolymyxin BTetracycline

Autor:innen und Institutionen

  • Department of Emergency Medicine, The First People's Hospital Of Jiashan County, Jiaxing 314100 Zhejiang, China.

Zitieren

APA

Wang, D., Yang, J., Yang, L., Du, Y., Zhu, Q., Ma, C., & Zhou, D. (2024). Combination therapy strategies against multidrug resistant bacteria in vitro and in vivo. Letters in Applied Microbiology. https://doi.org/10.1093/lambio/ovae129

Vancouver

Wang D, Yang J, Yang L, Du Y, Zhu Q, Ma C, et al. Combination therapy strategies against multidrug resistant bacteria in vitro and in vivo. Letters in Applied Microbiology. 2024. doi:10.1093/lambio/ovae129

BibTeX
@article{Wang2024,
  author = {Wang, Daliang and Yang, Jie and Yang, Lilan and Du, Yanglin and Zhu, Qunchao and Ma, Chendong and Zhou, Dongdong},
  title = {Combination therapy strategies against multidrug resistant bacteria in vitro and in vivo},
  journal = {Letters in Applied Microbiology},
  year = {2024},
  doi = {10.1093/lambio/ovae129}
}
Kostenlos starten →